CND Life Sciences Partners with Soleo Health to Broaden Availability of CND’s Neurodiagnostic Tests

Read about our partnership

Company to Distribute Recent FDA-Approved Treatment for Reducing Bad Cholesterol FRISCO, Texas, July 26, 2022 – Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been selected as a limited distribution partner for cardiovascular drug LEQVIO®, manufactured by Novartis, a leading global medicines company. LEQVIO (inclisiran) injection is indicated as […]

Company Named as a Specialty Pharmacy to Distribute Newly FDA-Approved Oral Suspension Treatment for Amyotrophic Lateral Sclerosis (ALS) FRISCO, Texas, June 7, 2022 – Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it was named one of only four limited distribution drug (LDD) specialty pharmacy partners to dispense nationwide RADICAVA […]

Company to Administer First FDA-Approved PH1 Drug to Lower Urinary Oxalate Levels FRISCO, Texas, January 11, 2022 – Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has access to OXLUMO™ (lumasiran), managed by Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company. This access allows Soleo Health to administer OXLUMO to lower […]

Company’s Clinical Center of Excellence Team Serves Thyroid Eye Disease Patients Nationally through 21 Strategically Located Specialty Pharmacies FRISCO, Texas, September 13, 2021 – Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the unveiling of its Thyroid Eye Disease (TED) Therapeutic Care Management Center (TCMC), dedicated to caring for […]

Company to Administer First FDA-Approved GalNAc-Conjugate RNA Therapeutic FRISCO, Texas, March 9, 2021 – Soleo Health, an innovative leader and national provider of complex specialty pharmacy and infusion services, announced today it has joined the treatment center directory for GIVLAARI® (givosiran), managed by Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company. This inclusion allows Soleo Health to administer […]

Program Designed to Reduce or Avoid Unnecessary Hospitalizations, Readmissions and Emergency Room Visits FRISCO, Texas, July 13, 2020 – Soleo Health, an innovative leader and national provider of complex specialty pharmacy and infusion services, announced today the capabilities of its new Soleo Direct™ program. Soleo Direct is a care path alternatives program designed to reduce […]